BL-M08D1 / Sichuan Biokin Pharmaceutical, Systimmune - LARVOL DELTA

A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (clinicaltrials.gov) - P1/2 | N=204 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

New P1/2 trial • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors (clinicaltrials.gov) - P1/2 | N=30 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

New P1/2 trial • Head and Neck Cancer • Nasopharyngeal Carcinoma • Oncology • Solid Tumor

A Study of BL-M08D1 in Patients With Recurrent or Metastatic Gynecological Malignancies and Other Solid Tumors (clinicaltrials.gov) - P1/2 | N=90 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

New P1/2 trial • Gynecologic Cancers • Oncology • Solid Tumor

A Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors (clinicaltrials.gov) - P2 | N=30 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

New P2 trial • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck

A Study of BL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors (clinicaltrials.gov) - P1/2 | N=60 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

New P1/2 trial • Gastrointestinal Cancer • Oncology • Solid Tumor

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors (ChiCTR) - P1 | N=22 | Recruiting | Sponsor: Fudan University Shanghai Cancer Center; Fudan University Shanghai Cancer Center

New P1 trial • Solid Tumor

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - P1 | N=22 | Recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology • Solid Tumor

A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies (clinicaltrials.gov) - P1 | N=22 | Recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting | Trial completion date: Jun 2027 ➔ Dec 2027 | Trial primary completion date: Dec 2026 ➔ Jun 2027

Enrollment open • Trial completion date • Trial primary completion date • Hematological Malignancies • Oncology